Pancreatic and biliary tract disorders in inflammatory bowel disease.
Hepatobiliary disorders occur frequently in patients with IBD, with PSC and cholangiocarcinoma being the most clinically significant for endoscopists. Endoscopic therapy for PSC is effective in improving symptoms, biochemical parameters, and radiographic abnormalities. Endoscopic therapy may also confer survival benefit, but this has yet to be confirmed in randomized, controlled trials. Treatment should be restricted to those individuals with a rapid decline in liver function testing or those with recurrent cholangitis. Cholangiocarcinoma is a serious complication of PSC and carries an extremely poor prognosis. ERCP with brush cytology has a relatively low sensitivity and the diagnosis is usually made after the disease has become metastatic. Malignant biliary obstruction can be palliated by endoscopic stenting. Photodynamic therapy is a promising experimental technique that may confer symptomatic and survival benefit in patients with nonresectable, advanced cholangiocarcinoma. IBD patients also have an elevated risk for developing acute and chronic pancreatitis as well as pancreatic insufficiency. The majority of cases of acute pancreatitis are likely due to medication side effects and local structural complications of IBD. The remainder may possibly represent true extraintestinal manifestations of IBD. Chronic pancreatitis is frequently subclinical, but may be accompanied by clinically relevant exocrine insufficiency. ERCP is the test of choice for the diagnosis of chronic pancreatitis, but the role of endoscopy in the therapeutic management of IBD-associated chronic pancreatitis remains to be defined.
Huang
Christopher
C
Boston University School of Medicine, Boston Medical Center, Section of Gastroenterology, 88 East Newton Street, Boston, MA 02118, USA.
Lichtenstein
David R
DR
D001650:Bile Duct Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D001653:Bile Ducts, Intrahepatic; D001660:Biliary Tract Diseases / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D018281:Cholangiocarcinoma / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D015209:Cholangitis, Sclerosing / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D016099:Endoscopy, Gastrointestinal; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000175:diagnosis; D010182:Pancreatic Diseases / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D010195:Pancreatitis / Q000150:complications / Q000175:diagnosis / Q000628:therapy